Compound class:
Synthetic organic
Comment: Abimtrelvir is a newly proposed INN for an antiviral that was revealed in January 2022, in the COVID special section of Proposed List 126. It is therefore assumed to target SARS-CoV-2, and to be a potential drug for the treatment of patients with SARS-CoV-2 infection (COVID-19). Abimtrelvir appears to be from the same chemical series as ensitrelvir.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
(6E)-6-[(6-chloro-2-methyl-2H-indazol-5-yl)imino]-3-(5-methylpyridin-3-yl)-1-[(3,4,5-trifluorophenyl)methyl]-1,3,5-triazinane-2,4-dione |
Database Links ![]() |
|
CAS Registry No. | 2647530-75-2 (source: WHO INN list) |
GtoPdb PubChem SID | 461663426 |
PubChem CID | 162623517 |
Search Google for chemical match using the InChIKey | FTIFIZZEWIBTMR-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | FTIFIZZEWIBTMR |
UniChem Compound Search for chemical match using the InChIKey | FTIFIZZEWIBTMR-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | FTIFIZZEWIBTMR-UHFFFAOYSA-N |